Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Flowhub is Automating Cannabis From Seed to Sale

There is no doubt that the marijuana industry in the US has a lot of growth potential. The sale of medical and recreational weed is expected to reach $30 billion by 2021 from $6.50 billion this year. However, the opportunities to invest in the industry are pretty limited. There are many cannabis companies trading on over-the-counter market, some of which are even pure-play cannabis stocks, but investing in OTC stocks is highly risky due to less regulatory control over what these companies are telling investors about their performance. In this way, you are left with a bunch of bigger companies listed on NYSE or NASDAQ, most of which are pharmaceutical companies, such as AbbVie Inc. (NYSE:ABBV) or GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH).

AbbVie Inc. (NYSE:ABBV) is one of the biggest pharmaceutical companies with exposure to the cannabis industry due to Marinol, a cannabis-based drug that helps chemotherapy patients with nausea. However, Marinol has a very small impact on Abbvie Inc. (NYSE:ABBV)’s revenues and because of its size, Abbvie Inc. (NYSE:ABBV) is pretty far from offering investors the opportunity to bet on the cannabis industry. GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH)’s pipeline is focused around cannabis-based drugs, such as Sativex, a spray medication that helps with spasticity in patients suffering from multiple sclerosis. In addition, GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH) also has under review from the European Medicines Agency and the US Food and Drug Administration Epidiolex (cannabidiol) for the adjunctive treatment of seizures associated with Lennox-Gastaut syndrome and Dravet syndrome.

Among non-pharma cannabis stocks, investors can consider Scotts Miracle-Gro Co (NYSE:SMG), whose core business involves lawn care, fertilizers and pesticides. However, to address a slowdown in its core business, Scotts Miracle-Gro Co (NYSE:SMG) has been engaging in cannabis-related businesses and has made several acquisitions since 2015 via its Hawthorne Operating unit. To capitalize on cannabis legalization, Scotts Miracle-Gro Co (NYSE:SMG) has acquired Agrolux, Botanicare, Gavita, General Hydroponics and Vermicrop. Its latest acquisition is Canada-based Can-Filters, which makes filters, fans and accessories for hydroponics. Scotts Miracle-Gro Co (NYSE:SMG) also made a big investment in AeroGrow, having expanded its stake to 80% from 30% in 2016. AeroGrow is known for Miracle-Gro AeroGarden, a smart countertop indoor garden, which allows growing various herbs, vegetables, and cannabis.

Given the limited choices among publicly-traded companies, investors that want to bet on the marijuana industry should look at the private sector. There are many cannabis-related startups, one of which is Flowhub. Because it’s a private company, the only option to invest in Flowhub is through a fund like Phyto Partners. Here is what Phyto Partners has to say about Flowhub.

Flowhub’s mission is to provide a world class Seed-to-Sale Solution that sets the standard for supply chain visibility, regulatory compliance, and effortless inventory and operations management within the cannabis industry. Flowhub saw grow managers and marijuana businesses struggling with their current technology, so they set out to devise a better way.

Flowhub’s state-of-the-art POS solution reports directly to METRC, automates discounts, & offers increased visibility over your cannabusiness. Their suite of tools has grown to epic proportions. With too many features and modules to list in this article. Suffice to say if you are a grower or a retailer, Flowhub solutions will be at the core of your operations. And everything will be seamless and in the cloud, constantly updated with mission-critical support and pretty much the best tech minds in the space.

Marijuana Investment Fund Opportunity – Flowhub

Their client pricing structure is based on licensing and is leased on a month-to-month, cancel anytime basis. As a private company, the only way to invest in Flowhub is through an investment fund like Phyto Partners.

Phyto Partners provides a vehicle for accredited investors to join a top 5 marijuana investment fund rated by Forbes Magazine. See our marijuana investment portfolio.

Learn more about Flowhub at https://flowhub.co/

 

Disclosure: The opinions expressed in this article are Insider Monkey’s writer, Alex Oleinic’s. Alex does not have positions in AbbVie Inc. (NYSE:ABBV), GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH), Scotts Miracle-Gro Co (NYSE:SMG). Insider Monkey received compensation in exchange for publishing this article. Insider Monkey doesn’t recommend purchase/sale of any securities. Please get in touch with a financial professional before making any financial decisions. You understand that Insider Monkey doesn’t accept any responsibility and you will be using the information presented here at your own risk. You acknowledge that this disclaimer is a simplified version of our Terms of Use, and by accessing or using our site, you agree to be bound by all of its terms and conditions. If at any time you find these terms and conditions unacceptable, you must immediately leave the Site and cease all use of the Site.

Loading...